Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma
Jonas Busch(Charité - Universitätsmedizin Berlin), Carsten Kempkensteffen(Charité - Universitätsmedizin Berlin), Barbara Erber(Charité - Universitätsmedizin Berlin), Stefan Hinz(Charité - Universitätsmedizin Berlin), Frank Friedersdorff(Charité - Universitätsmedizin Berlin), Ingmar Wolff(Universitätsmedizin Greifswald), Ahmed Magheli(Johns Hopkins University), Irena Goranova(Charité - Universitätsmedizin Berlin), Kurt Miller(Charité - Universitätsmedizin Berlin)
Cited by 7
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594